Hi mr jezza. l cant see this as a threat. While its great news for children requiring a transplant it would be a limited market.
With Heartware about to trial their miniature device maybe they will look at children for that.
Just wish the FDA would hurry up. If the FDA allow HIN to continue implanting under the CAP plan and have US health system pay for them and they have now implanted way over 1000 worldwide with good results whats the problem?
HIN Price at posting:
$1.90 Sentiment: Buy Disclosure: Held
